Your browser doesn't support javascript.
loading
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
Green, Kile; Pearce, Kim; Sellar, Rob S; Jardine, Laura; Nicolson, Phillip L R; Nagra, Sandeep; Bigley, Venetia; Jackson, Graham; Dickinson, Anne M; Thomson, Kirsty; Mackinnon, Stephen; Craddock, Charles; Peggs, Karl S; Collin, Matthew.
Afiliação
  • Green K; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Pearce K; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Sellar RS; Cancer Institute, University College London, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Jardine L; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Northern Centre for Bone Marrow Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Nicolson PLR; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Nagra S; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Bigley V; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Northern Centre for Bone Marrow Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Jackson G; Northern Centre for Bone Marrow Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Dickinson AM; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Thomson K; Cancer Institute, University College London, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Mackinnon S; Cancer Institute, University College London, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Craddock C; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Peggs KS; Cancer Institute, University College London, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Collin M; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Northern Centre for Bone Marrow Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address: matthew.collin@newcastle.ac.uk.
Biol Blood Marrow Transplant ; 23(5): 805-812, 2017 May.
Article em En | MEDLINE | ID: mdl-28212937
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido